{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"adrenomyodystrophy","columns":[{"gene":"","key":"population-71dfb4b699a1519d1a36","label":"Adrenomyodystrophy","mondoId":"MONDO:0010288","onsetQualifier":null,"originColumnKey":"MONDO:0010288/ORPHA:977","originalViews":[{"key":"MONDO:0010288/ORPHA:977","label":"Adrenomyodystrophy","scopeLabel":"ORPHA:977","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0742511ab6dbd86c6a5a1069ef3dcdb18f3d489aaf9850551a7b21b3b52a15f2","0a237eed1077fd8f0c122e0522758f70fab9f1a47b4f1d1a1eac219a13e94b8f","230273127931c9a38f73be04507f326ea29d99d7e18a1b4f50c6c87763c0fb9d","365d2904017289103bb507bf8008384a81049f3a412a5cd2328a5a8739ddf00c","503a05dd7bbf0fc4f61018d7178247faba15ae6feb72f820ad2e078abad45920","65e210ba8ce48086a0933e1b842fc5755edfd757630df0e643bd0ee1e8423b15","6ca8361ddb8559ebc54bc6fa03cf27d7140c908c6be4b9299b3cf496b6f3e67e","93cb3b999427083f0b5281b97adcdc154dfa7c8a3c08ce7b6c1bca4b5cb349c2","95b0c5b90e18de2b4fc855b9683bf515de94e830057cf6db793e3cc7ed4473e0","9e174d5b384c8e6d52a39b9d0fe64cb8773061a3ae3d275c5f9d6c741ffab348","ae979a6b2def3367221989938a43a60299c2ed1d0d37dac379e24e8e7ef22804","c7e1e831a95039125a70f60e496380373931439a854946ce1be5f87a2db71927","cb934e3f4c71037fd8ddc8f3c76002d8adc47b57278cd3cd3f262b74650658da","e07cb76910ff2ca0aa8c33783b56f06bbebec8abdd0ac8da171d991e639938a8","e52e8346906363eee9020d27c95466de470248c16e47993b8dd874e07ad8d013","ecb4b18768b34f1d62f731ea614277b9e5c9a0c5a2fc27dccb2718d6162a9bdc"],"recordQualifiers":{},"scopeLabel":"ORPHA:977","sourceIds":["ORPHA:977"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-71dfb4b699a1519d1a36"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002242","HP:0000079","HP:0002750","HP:0003457","HP:0001508","HP:0007440","HP:0001397"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":16,"sourceGroups":{"orphanet":16}},"features":[{"hpoId":"HP:0002242","label":"Abnormal intestine morphology","primary":true},{"hpoId":"HP:0000079","label":"Abnormality of the urinary system","primary":true},{"hpoId":"HP:0002750","label":"Delayed skeletal maturation","primary":true},{"hpoId":"HP:0003457","label":"EMG abnormality","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":true},{"hpoId":"HP:0007440","label":"Generalized hyperpigmentation","primary":true},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":true},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0000021","label":"Megacystis","primary":false},{"hpoId":"HP:0000485","label":"Megalocornea","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0008207","label":"Primary adrenal insufficiency","primary":false},{"hpoId":"HP:0004349","label":"Reduced bone mineral density","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0011344","label":"Severe global developmental delay","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false}],"ledeHtml":"An extremely rare genetic endocrine disease characterized by primary adrenal insufficiency, dystrophic myopathy, hepatic steatosis, severe psychomotor delay, megalocornea, failure to thrive, chronic constipation, and terminal bladder ectasia which can lead to death. There have been no further descriptions in the literature since 1982.","mondoId":"MONDO:0010288","node":{"canonicalSlug":"adrenomyodystrophy","comparisons":[{"documentSha256":"14b8fe14a4ab2f227b59a76e16076d45a6eac6a51a28efbf862c154a46a5ada5","key":"legacy-adrenomyodystrophy","kind":"legacy","label":"adrenomyodystrophy","memberIds":["MONDO:0010288"],"mondoId":"MONDO:0010288","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/adrenomyodystrophy.14b8fe14a4ab2f227b59a76e16076d45a6eac6a51a28efbf862c154a46a5ada5.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Adrenomyodystrophy","originalSourceId":"ORPHA:977","paragraphs":["An extremely rare genetic endocrine disease characterized by primary adrenal insufficiency, dystrophic myopathy, hepatic steatosis, severe psychomotor delay, megalocornea, failure to thrive, chronic constipation, and terminal bladder ectasia which can lead to death. There have been no further descriptions in the literature since 1982."],"rawAttribution":"MONDO:0010288","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:05:33Z","upstream":"MONDO:0010288","url":"https://rarediseases.info.nih.gov/diseases/562"},"ownColumnKeys":["population-71dfb4b699a1519d1a36"],"publication":"published","relationships":[{"kind":"parent","label":"adrenal gland disorder","mondoId":"MONDO:0005495","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0742511ab6dbd86c6a5a1069ef3dcdb18f3d489aaf9850551a7b21b3b52a15f2","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000021","is_excluded":false,"label":"Megacystis","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0a237eed1077fd8f0c122e0522758f70fab9f1a47b4f1d1a1eac219a13e94b8f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002750","is_excluded":false,"label":"Delayed skeletal maturation","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"230273127931c9a38f73be04507f326ea29d99d7e18a1b4f50c6c87763c0fb9d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"365d2904017289103bb507bf8008384a81049f3a412a5cd2328a5a8739ddf00c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004349","is_excluded":false,"label":"Reduced bone mineral density","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"503a05dd7bbf0fc4f61018d7178247faba15ae6feb72f820ad2e078abad45920","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"65e210ba8ce48086a0933e1b842fc5755edfd757630df0e643bd0ee1e8423b15","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003457","is_excluded":false,"label":"EMG abnormality","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6ca8361ddb8559ebc54bc6fa03cf27d7140c908c6be4b9299b3cf496b6f3e67e","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"93cb3b999427083f0b5281b97adcdc154dfa7c8a3c08ce7b6c1bca4b5cb349c2","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000079","is_excluded":false,"label":"Abnormality of the urinary system","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"95b0c5b90e18de2b4fc855b9683bf515de94e830057cf6db793e3cc7ed4473e0","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007440","is_excluded":false,"label":"Generalized hyperpigmentation","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9e174d5b384c8e6d52a39b9d0fe64cb8773061a3ae3d275c5f9d6c741ffab348","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000485","is_excluded":false,"label":"Megalocornea","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ae979a6b2def3367221989938a43a60299c2ed1d0d37dac379e24e8e7ef22804","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002242","is_excluded":false,"label":"Abnormal intestine morphology","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c7e1e831a95039125a70f60e496380373931439a854946ce1be5f87a2db71927","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011344","is_excluded":false,"label":"Severe global developmental delay","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb934e3f4c71037fd8ddc8f3c76002d8adc47b57278cd3cd3f262b74650658da","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008207","is_excluded":false,"label":"Primary adrenal insufficiency","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e07cb76910ff2ca0aa8c33783b56f06bbebec8abdd0ac8da171d991e639938a8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e52e8346906363eee9020d27c95466de470248c16e47993b8dd874e07ad8d013","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ecb4b18768b34f1d62f731ea614277b9e5c9a0c5a2fc27dccb2718d6162a9bdc","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:977","disease_name":"Adrenomyodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:977","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/562\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0010288\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0010288</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>An extremely rare genetic endocrine disease characterized by primary adrenal insufficiency, dystrophic myopathy, hepatic steatosis, severe psychomotor delay, megalocornea, failure to thrive, chronic constipation, and terminal bladder ectasia which can lead to death. There have been no further descriptions in the literature since 1982.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/562\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"adrenomyodystrophy","sourceDocuments":[{"name":"GARD: Adrenomyodystrophy","reviewed":null,"source_release":"2026-10-21T17:05:33Z","url":"https://rarediseases.info.nih.gov/diseases/562"},{"name":"MONDO: adrenomyodystrophy","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0010288"}],"sourceNote":"","synonyms":["adrenomyodystrophy"],"takeawayHtml":"","title":"adrenomyodystrophy"},"schemaVersion":1}
